ALKBH5 and hepatocellular carcinoma: In addition, in vitro experiments revealed that downregulated ALKBH5 and elevated cell mobility induced by miR‐3190‐enriched EVs was ablated in ALKBH5‐overexpressing HCC cells (Figure S8B–D, Supporting Information).